4//SEC Filing
Hata Yujiro S 4
Accession 0001610717-24-000053
CIK 0001676725other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:27 PM ET
Size
14.0 KB
Accession
0001610717-24-000053
Insider Transaction Report
Form 4
Hata Yujiro S
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2024-02-08$4.31/sh+75,815$326,763→ 753,702 total - Sale
Common Stock
2024-02-08$45.15/sh−75,815$3,422,835→ 677,887 total - Exercise/Conversion
Common Stock
2024-02-09$4.31/sh+23,557$101,531→ 701,444 total - Exercise/Conversion
Stock Option (right to buy)
2024-02-08−75,815→ 248,011 totalExercise: $4.31Exp: 2028-02-26→ Common Stock (75,815 underlying) - Sale
Common Stock
2024-02-09$45.54/sh−23,557$1,072,715→ 677,887 total - Exercise/Conversion
Stock Option (right to buy)
2024-02-09−23,557→ 224,454 totalExercise: $4.31Exp: 2028-02-26→ Common Stock (23,557 underlying)
Footnotes (4)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 11, 2023.
- [F2]This transaction was executed in multiple trades in prices ranging from $45.00 to $45.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]This transaction was executed in multiple trades in prices ranging from $45.01 to $45.82, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]The shares subject to the option are fully vested and exercisable.
Documents
Issuer
IDEAYA Biosciences, Inc.
CIK 0001676725
Entity typeother
Related Parties
1- filerCIK 0001649119
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:27 PM ET
- Size
- 14.0 KB